These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 18639950)
1. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. McConnell EL; Short MD; Basit AW J Control Release; 2008 Sep; 130(2):154-60. PubMed ID: 18639950 [TBL] [Abstract][Full Text] [Related]
2. Microbiota-triggered colonic delivery: robustness of the polysaccharide approach in the fed state in man. Basit AW; Short MD; McConnell EL J Drug Target; 2009 Jan; 17(1):64-71. PubMed ID: 19016069 [TBL] [Abstract][Full Text] [Related]
3. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline. Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450 [TBL] [Abstract][Full Text] [Related]
4. The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF Eur J Pharm Sci; 2004 Feb; 21(2-3):179-89. PubMed ID: 14757489 [TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive platforms for targeted delivery to the colon. Varum FJ; Veiga F; Sousa JS; Basit AW Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. Freire C; Podczeck F; Ferreira D; Veiga F; Sousa J; Pena A J Pharm Pharmacol; 2010 Jan; 62(1):55-61. PubMed ID: 20722999 [TBL] [Abstract][Full Text] [Related]
7. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720 [TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
9. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475 [TBL] [Abstract][Full Text] [Related]
10. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets. Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752 [TBL] [Abstract][Full Text] [Related]
11. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Liu F; Moreno P; Basit AW Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177 [TBL] [Abstract][Full Text] [Related]
12. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Siew LF; Man SM; Newton JM; Basit AW Int J Pharm; 2004 Apr; 273(1-2):129-34. PubMed ID: 15010137 [TBL] [Abstract][Full Text] [Related]
13. A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology. Ibekwe VC; Khela MK; Evans DF; Basit AW Aliment Pharmacol Ther; 2008 Oct; 28(7):911-6. PubMed ID: 18647282 [TBL] [Abstract][Full Text] [Related]
14. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317 [TBL] [Abstract][Full Text] [Related]
15. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets. Körber M; Ciper M; Hoffart V; Pearnchob N; Walther M; Macrae RJ; Bodmeier R Eur J Pharm Biopharm; 2011 Aug; 78(3):447-54. PubMed ID: 21443950 [TBL] [Abstract][Full Text] [Related]
16. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery. Freire C; Podczeck F; Veiga F; Sousa J Drug Dev Ind Pharm; 2010 Feb; 36(2):161-72. PubMed ID: 19678749 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers. Kranz H; Gutsche S Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313 [TBL] [Abstract][Full Text] [Related]
18. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy. Varum FJ; Hatton GB; Freire AC; Basit AW Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235 [TBL] [Abstract][Full Text] [Related]
19. In-vitro and in-vivo studies of pectin/ethylcellulosefilm-coated pellets of 5-fluorouracil for colonic targeting. Wei H; Qing D; De-Ying C; Bai X; Li-Fang F J Pharm Pharmacol; 2008 Jan; 60(1):35-44. PubMed ID: 18088503 [TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid. Xu M; Sun M; Qiao H; Ping Q; Elamin ES Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]